Maricann Group (CNSX:MARI) Price Target Raised to $6.00

Maricann Group (CNSX:MARI) had its price target raised by research analysts at Raymond James from $5.50 to $6.00 in a research report issued to clients and investors on Wednesday, BayStreet.CA reports. The firm currently has an “outperform” rating on the stock.

Maricann Group has a 52-week low of $0.87 and a 52-week high of $3.60.

Maricann Group Company Profile

Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company’s services a patient base with more than 8,000 registered patients.

Featured Article: Forex

Receive News & Ratings for Maricann Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maricann Group and related companies with's FREE daily email newsletter.